Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...
Labcorp Holdings Inc. , a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July ...
A healthcare company is preparing to pay $35,000,000 to settle a class action lawsuit over a cybersecurity incident that ...
LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.
ColoSense uses RNA-based methods to detect biomarkers linked to colorectal cancer and advanced adenomas, which are precancerous. Credit: Labcorp / PRNewswire. Labcorp has announced the availability of ...
Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and ...
Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and ...
New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatment BURLINGTON, N.C., May 28, 2026 ...
Good day, and thank you for standing by. Welcome to the Q1 2026 Labcorp Holdings Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...